APGE
Apogee Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$134.07+0.06%
Price as of Jul 20, 2026
APGE earnings
Apogee Therapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 10, 2026in NaN days
EPS est $-1.10 · Revenue est $10M
Track record
Beat EPS in 2 of 5 quarters
Avg surprise -6.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 11, 2026 | $-1.12 | $-1.06 | +5.4% | — | — |
| Mar 3, 2025 | $-0.94 | $-1.19 | -26.6% | — | — |
| Mar 5, 2024 | $-0.45 | $-0.32 | +28.9% | — | — |
| Nov 13, 2023 | $-0.38 | $-0.51 | -34.2% | — | — |
| Jul 17, 2023 | $-1.70 | $-3.78 | -122.4% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-10.